期刊文献+

载硫酸庆大霉素聚乳酸纳米粒制备的正交设计及体外释药行为研究 被引量:1

Optimization of Preparation Parameters for Gentamicin-loaded PLLA Nanoparticles and the Drug Release Behavior In Vitro
原文传递
导出
摘要 载药纳米粒的制备与应用是纳米生物医学研究中的重要方向之一,要获得释药性能稳定的载药纳米粒,需要解决的一个关键问题是确定重要工艺参数和进行制备工艺的优化。我们运用SPSS软件对复乳法制备载硫酸庆大霉素聚乳酸纳米粒(GS-PLLA-NPs)的工艺条件进行了正交设计优化,通过紫外-可见分光光谱对其体外释放行为进行了测定和分析。实验结果表明,PLLA的浓度与PLLA的分子量是影响GS-PLLA-NPs粒径分布均一性的关键因素,油水相之比对药物的释放行为有显著影响。在优化条件下制备的GS-PLLA-NPs粒径均匀,有较为理想的药物缓释效果,在抗骨术后感染、骨缺损修复等方面具有重要的应用价值。 It has been one of important issues in nanomedicine research field to prepare drug-loaded nanoparticles. Optimization of the preparation parameters plays a key role in obtaining drug-loaded nanoparticles with homogeneous particle size and controlled drug release property. In this paper, gentamicin-loaded PLLA nanoparticles was prepared by means of double emulsion and solvent evaporation technique. Statistical software SPSS was employed to deal with the orthogonal design for optimizing the parameters of the formulation. The in vitro release of gentamicin from nanoparticles was determined by ultra-violet spectroscopy. Analysis of the experimental data based on orthogo- nal design demonstrated that the concentration of PLLA solution and the molecular weight of PLLA had significant influence on the size of nanoparticles, and the ratio of oil phase to water phase exhibited determined role in the gentamicin release property. Gentamicin-loaded PLLA nanoparticles prepared with the optimized parameters showed homogeneous particle size of 277 nm and sustained release property, which displayed a promising potential of clinical applications.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2009年第2期351-355,共5页 Journal of Biomedical Engineering
基金 国家纳米中心资助项目
关键词 纳米粒 正交设计 聚乳酸 硫酸庆大霉素 复乳法 Nanoparticles Orthogonal design Poly (L-lactic acid) Gentamicin sulfate Double e-mulsion
  • 相关文献

参考文献15

  • 1CLAUS-PETER A. Bone Diseases: macroscopic, histological, and radiological diagnosis of structural changes in the skeleton[M]. Berlin: Springer, 2000:129-158.
  • 2LEE CG, FU Y C, WANG C H. Simulation of gentamiein delivery for the local treatment of osteomyelitis[J]. Biotechnol Bioeng, 2005, 91(5) : 622.
  • 3ZALAVRAS C G, PATZAKIS M J, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis[J]. Clin Orthop Relat Res, 2004, 427 : 86.
  • 4EL-GHANNAM A, AHED K, OMRAN M. Nanoporous delivery system to treat osteomyelitis and regenerate bone: gentamicin release kinetics and bactericidal effect[J]. J Biomed Mater Res B Appl Biomater, 2005, 73(2) : 277.
  • 5JOOSTEN U, JOIST A, FREBEL T, et al. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamiein in the treatment of chronic osteomyelitis: studies in vitro and in vivo[J]. Biomaterials, 2004, 25 (18) : 4287.
  • 6NARAHARISETTI P K, GUAN LEE H C, Fu Y C, et al. In vitro and in vivo release of gentamicin from biodegradable discs[J]. J Biomed Mater Res B Appl Biomater, 2006; 77(2) : 329.
  • 7STALLMANN H P, FABER C, BRONCKERS A L, et al. In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile[J]. BMC Musculoskelet Disord, 2006, 26(7) : 18
  • 8汤善华,靳安民,王永峰,于博,王旭东.可塑性纳米羟基磷灰石/聚羟基丁酸酯-羟基戊酸酯共聚物-聚乙二醇庆大霉素释药系统研制[J].中国修复重建外科杂志,2006,20(7):758-761. 被引量:9
  • 9Lucas-Girot A, Verdier MC, Tribut O, et al. Gentamicinloaded calcium carbonate materials: comparison of two drugloading modes. J Biomed Mater Res B Appl Biomater, 2005, 73 (1) : 164.
  • 10NARAHARISETTI P K, LEW M D, FU Y C, et al. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release[J]. J Control Release, 2005, 102 (2) : 345.

二级参考文献14

  • 1孙效棠,赵黎,胡蕴玉,李丹,袁志,崔庚,杜俊杰.磷酸钙骨水泥载药核心的块型重组合异种骨体内缓释及修复兔长段感染性骨缺损的研究[J].中国修复重建外科杂志,2005,19(3):165-169. 被引量:15
  • 2梁军,杨志明,罗静聪,李秀群.WO-1生物衍生骨缓释材料抗感染的实验研究[J].中国修复重建外科杂志,2005,19(5):369-372. 被引量:15
  • 3于胜吉,邱贵兴,辛大江,陈晓峰,郑裕东,王迎军.羟基丁酸-戊酸共聚物/生物活性玻璃复合多孔支架材料对骨缺损的修复作用[J].中国医学科学院学报,2005,27(2):185-189. 被引量:10
  • 4Joosten U,Joist A,Gosheger G,et al.Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.Biomaterials,2005,26(25):5251-5258.
  • 5Buranapanitkit B,Srinilta V,Ingviga N,et al.The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system.Clin Orthop Relat Res,2004,424:244-252.
  • 6Mendel V,Simanowski HJ,Scholz HCh.Synergy of HBO2 and a local antibiotic carrier for experimental osteomyelitis due to Staphylococcus aureus in rats.Undersea Hyperb Med,2004,31(4):407-416.
  • 7Wang G,Liu SJ,Ueng SW,et al.The release of cefazolin and gentamicin from biodegradable PLA/PGA beads.Int J Pharm,2004,273(1-2):203-212.
  • 8Woods GL,Washington JA.Antibacterial susceptibility test,dilution and disk diffusion methods.In:MurrayPR,ed.Manual of clinical microbiology.Washington:American Socjety Microbiology,1995.1327-341.
  • 9Silverman RP,Bonasser L,Passaretti D,et al.Adhesion of tissue-engineered cartilate to native cartilage.Plast Reconstr Surg,2000,105(4):1393-1398.
  • 10Deng X,Hao J,Wang C.Preparation and mechanical properties of nanocomposites of play(D,L-Lactide) with Ca-deficient hydroxyapatite nanocrystal.Biomaterials,2001,22(21):2867-2873.

共引文献8

同被引文献11

  • 1沈涛,刘俊成,翟慎秋,张国栋.晶体生长用石英玻璃管镀膜工艺的正交实验研究[J].人工晶体学报,2009,38(1):271-275. 被引量:3
  • 2祝国强,滕海英,黄平.正交试验设计方法在医药学中的应用[J].数理医药学杂志,2007,20(4):568-569. 被引量:36
  • 3ZUR HAUSEN H. Papillomaviruses and cancer., from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2 (5) : 342-350.
  • 4XUE Y, BELLANGER S, ZHANG W, et al. HPV16 E2 is an immol/Ledlate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma [J]. Cancer Res, 2010, 70(13):5316-5325.
  • 5MOLE S, MILLIGAN S G, GRAHAM S V. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SFZ/ASF [J]. J Virol, 2009, 83(1) ,357-367.
  • 6WU Y C, ROARK A A, BIAN X L, et al. Modifieation of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs)[J]. Virology, 2008, 378(2):329- 338.
  • 7DAS D, BHATTACHARJEE B, SEN S, et al. Association of viral load with HPV16 positive cervical cancer pathogenesis: causal relevance in isolates harboring intact viral E2 gene [J]. Virology, 2010, 402(1):197-202.
  • 8DILLON S, SASAGAWA T, CRAWFORD A, et al. Resolution of cervical dysplasia is associated with T-cell prolifera- tive responses to human papillomavirus type 18 E2 [J]. J Gen Virol, 2007, 88(3) : 803-813.
  • 9LID C, JIANG J G. Optimization of the microwave-assisted extraction conditions of tea polyphenols from green tea [J]. Int J Food Sci Nutr, 2010, doi, 10. 3109/09637486. 2010. 489508.
  • 10BUNGER M K, CARGILE B J, SEVINSKY J R, et al. Detection and validation of non-synonymous coding SNPs from orthogonal analysis of shotgun proteomics data [J]. J Proteome Res, 2007, 6(6) :2331-2340.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部